TickerFactsScreenerDevelopers

CRESCENT BIOPHARMA, INC. (CBIO) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2011: $28.17M2012: $17.37M2013: $2.31M2014: $55.20M2015: $46.80M2016: $40.04M2017: $123.92M2018: $209.92M2019: $158.20M2020: $137.04M2021: $90.25M2022: $47.87M2023: $41.79M2024: $34.77M2025: $213.19M$213.19M
2011Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$213.19M+513.2%
2024$34.77M-16.8%
2023$41.79M-12.7%
2022$47.87M-47.0%
2021$90.25M-34.1%
2020$137.04M-13.4%
2019$158.20M-24.6%
2018$209.92M+69.4%
2017$123.92M+209.5%
2016$40.04M-14.4%
2015$46.80M-15.2%
2014$55.20M+2288.9%
2013$2.31M-86.7%
2012$17.37M-38.3%
2011$28.17M—